• Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against NovoCure Limited (NVCR) And Encourages Shar... ACCESS Newswire Mon, 06 Jul 2026 16:50:58 GMT
• Is NovoCure (NVCR) Cheap As TRIDENT Fallout Clouds Its Valuation? simplywall.st Mon, 06 Jul 2026 03:29:08 GMT
• novocure limited (nvcr) investigation: bronstein, gewirtz & grossman, llc encourages investors to contact the firm to learn more a... ACCESS Newswire Fri, 03 Jul 2026 16:39:39 GMT
• bronstein, gewirtz & grossman, llc announces an investigation aga The National Law Review Thu, 02 Jul 2026 16:07:49 GMT
• nvcr stock gains after novocure announces positive topline results in metastatic pancreatic cancer therapy trial Stocktwits Thu, 02 Jul 2026 14:03:41 GMT
• NovoCure (NVCR) CHRO acquires 1,905 discounted shares in ESPP purchase Stock Titan Wed, 01 Jul 2026 20:34:26 GMT
• NovoCure (NVCR) CEO adds 1,905 shares through 2025 employee share purchase plan Stock Titan Wed, 01 Jul 2026 20:32:13 GMT
• NovoCure (NVCR) General Counsel adds 1,299 ESPP shares to holdings Stock Titan Wed, 01 Jul 2026 20:32:03 GMT
• NovoCure (NASDAQ: NVCR) director adds shares through 2025 employee stock purchase plan Stock Titan Wed, 01 Jul 2026 20:30:58 GMT
• novocure limited (nvcr) investigation: bronstein, gewirtz & gross The National Law Review Wed, 01 Jul 2026 15:44:23 GMT
• Novocure to Report Second Quarter 2026 Financial Results Business Wire Wed, 01 Jul 2026 11:00:00 GMT
• novocure's optune pax receives eu ce mark for pancreatic cancer treatment GuruFocus Wed, 01 Jul 2026 07:45:15 GMT
• NovoCure's Cancer Treatment Device Option Pax Gets European Approval Yahoo Finance Wed, 01 Jul 2026 07:00:00 GMT
• heartflow vs. novocure: which emerging healthcare stock is a better buy in 2026? AOL.com Wed, 01 Jul 2026 00:43:01 GMT
• law firm probes novocure for possible securities fraud after trial results disappoint investors Pluang Tue, 30 Jun 2026 21:28:03 GMT
• Novocure earns CE mark for Optune Pax pancreatic cancer treatment device MassDevice Tue, 30 Jun 2026 16:12:59 GMT
• bronstein, gewirtz & grossman, llc is investigating novocure limited (nvcr) and encourages investors to connect The National Law Review Tue, 30 Jun 2026 15:52:44 GMT
• novocure's optune pax receives eu ce mark for pancreatic cancer treatment GuruFocus Tue, 30 Jun 2026 15:23:09 GMT
• Novocure wins CE Mark for Optune Pax pancreatic cancer treatment grafa.com Tue, 30 Jun 2026 14:23:09 GMT
• NovoCure Says Optune Pax Receives CE Mark for Locally Advanced Pancreatic Cancer Treatment marketscreener.com Tue, 30 Jun 2026 13:53:33 GMT
• Novocure (NVCR) Gains CE Mark for New Pancreatic Cancer Treatmen GuruFocus Tue, 30 Jun 2026 12:48:10 GMT
• Novocure receives CE Mark for pancreatic cancer device in Europe Investing.com Tue, 30 Jun 2026 11:39:27 GMT
• Optune Pax CE Mark expands Novocure (NASDAQ: NVCR) pancreatic cancer reach Stock Titan Tue, 30 Jun 2026 11:00:55 GMT
• Novocure’s Optune Pax® Receives CE Mark for the Treatment of Locally Advanced Pancreatic Cancer Business Wire Tue, 30 Jun 2026 11:00:00 GMT
• wearable pancreatic cancer device optune pax wins ce mark in europe Stock Titan Tue, 30 Jun 2026 11:00:00 GMT
• bronstein, gewirtz & grossman, llc encourages novocure limited (n The National Law Review Mon, 29 Jun 2026 15:25:11 GMT
• NovoCure Limited(NasdaqGS: NVCR) added to Russell 2000 Value Benchmark marketscreener.com Mon, 29 Jun 2026 15:10:57 GMT
• Enterprise value to EBIT forward of NovoCure Limited – NASDAQ:NVCR TradingView Mon, 29 Jun 2026 13:20:38 GMT
• bronstein, gewirtz & grossman, llc announces an investigation against novocure limited (nvcr) and encourages investors to learn mo... ACCESS Newswire Mon, 29 Jun 2026 10:01:54 GMT
• Price to earnings forward of NovoCure Limited – NASDAQ:NVCR TradingView Mon, 29 Jun 2026 02:55:30 GMT
• Enterprise value to revenue forward of NovoCure Limited – NASDAQ:NVCR TradingView Mon, 29 Jun 2026 00:46:35 GMT
• NovoCure Limited(NasdaqGS: NVCR) added to Russell 3000E Value Benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• nvcr rallies on fda approval for cancer treatment device, analyst still sees 275% potential upside Stocktwits Sun, 28 Jun 2026 16:33:14 GMT
• novocure (nvcr) is up 8.1% after trident shows no survival gain from earlier ttfields start Sahm Sun, 28 Jun 2026 14:25:20 GMT
• NovoCure (NVCR) Is Up 8.1% After TRIDENT Shows No Survival Gain From Earlier TTFields Start simplywall.st Sat, 27 Jun 2026 12:32:17 GMT
• enterprise value to ebitda forward of novocure limited – nasdaq:nvcr TradingView Sat, 27 Jun 2026 11:18:03 GMT
• novocure ltd. shs unsponsored brazilian depositary receipt repr 0.1 sh TradingView Sat, 27 Jun 2026 07:51:15 GMT
• novocure ltd. shs unsponsored brazilian depositary receipt repr 0.1 sh TradingView Fri, 26 Jun 2026 20:11:33 GMT
• bronstein, gewirtz & grossman, llc is investigating novocure limi The National Law Review Fri, 26 Jun 2026 15:35:56 GMT
• NovoCure (NVCR) Could Be 42% Undervalued On Mixed TRIDENT Trial Results simplywall.st Fri, 26 Jun 2026 06:22:10 GMT
• novocure limited (nvcr) investigation: bronstein, gewirtz & grossman, llc encourages stockholders to contact the firm to learn mor... ACCESS Newswire Thu, 25 Jun 2026 22:00:57 GMT
• INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NovoCure Limited - NVCR PR Newswire Thu, 25 Jun 2026 07:00:00 GMT
• novocure (nvcr) could be 42% undervalued on mixed trident trial results Sahm Thu, 25 Jun 2026 07:00:00 GMT
• bronstein, gewirtz & grossman, llc announces an investigation against novocure limited (nvcr) and encourages stockholders to learn... ACCESS Newswire Wed, 24 Jun 2026 16:14:08 GMT
• 2026-06-24 | bronstein, gewirtz & grossman, llc announces an investigation against novocure limited (nvcr) and encourages stockhol... Stockhouse Wed, 24 Jun 2026 15:00:00 GMT
• HeartFlow vs. NovoCure: Which Emerging Healthcare Stock Is a Better Buy in 2026? The Motley Fool Wed, 24 Jun 2026 07:00:00 GMT
• why nvcr stock is surging nearly 30% in overnight trading Stocktwits Wed, 24 Jun 2026 02:07:32 GMT
• 2026-06-23 | bronstein, gewirtz & grossman, llc encourages novocure limited (nvcr) investors to inquire about securities investiga... Stockhouse Tue, 23 Jun 2026 15:00:00 GMT
• NovoCure vs. Omeros: Which Emerging Pharmaceutical Stock Is a Better Buy in 2026? aol.com Tue, 23 Jun 2026 01:13:28 GMT
• NovoCure vs. Omeros: Which Emerging Pharmaceutical Stock Is a Better Buy in 2026? The Motley Fool Mon, 22 Jun 2026 07:00:00 GMT
• H.C. Wainwright Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $46 Moomoo Mon, 22 Jun 2026 07:00:00 GMT
• amgen vs. novocure: which health care stock is a better buy in 2026? AOL.com Mon, 22 Jun 2026 06:26:31 GMT
• novocure shares slide after phase 3 glioblastoma study falls short of survival goal MSN Mon, 22 Jun 2026 04:34:39 GMT
• novocure's brain cancer treatment fails to meet late-stage trial goal ETPharma.com Mon, 22 Jun 2026 01:02:53 GMT
• NovoCure: Solid Fundamentals, But TRIDENT Caps Near-Term Upside (NASDAQ:NVCR) Seeking Alpha Sun, 21 Jun 2026 07:00:00 GMT
• novocure limited (nvcr) securities fraud investigation - levi & korsinsky ACCESS Newswire Sun, 21 Jun 2026 04:23:43 GMT
• NovoCure (NVCR) Stock Could Be 45.2% Below Fair Value After TRIDENT Trial Miss Yahoo Finance Sat, 20 Jun 2026 07:00:00 GMT
• NVCR Investors Have Opportunity to Join NovoCure Limited Fraud Investigation with the Schall Law Firm Business Wire Sat, 20 Jun 2026 07:00:00 GMT
• novocure (nvcr) is down 19.7% after trident misses survival endpoint in earlier ttfields use simplywall.st Sat, 20 Jun 2026 01:48:12 GMT
• novocure (nvcr) stock could be 31.5% undervalued after trident trial result Sahm Fri, 19 Jun 2026 21:59:03 GMT
• Amgen vs. NovoCure: Which Health Care Stock Is a Better Buy in 2026? The Motley Fool Fri, 19 Jun 2026 07:00:00 GMT
• novocure (nvcr) is down 19.7% after trident misses survival endpoint in earlier ttfields use Sahm Fri, 19 Jun 2026 07:00:00 GMT
• novocure’s glioblastoma trial fails primary endpoint by investing.com Investing.com India Fri, 19 Jun 2026 06:46:09 GMT
• novocure announces topline data from the phase 3 trident trial evaluating earlier use of tumor treating fields therapy in newly di... BioSpace Fri, 19 Jun 2026 04:14:43 GMT
• novocure limited investigation initiated: suewallst investigates the officers and directors of novocure limited (nvcr) Barchart.com Fri, 19 Jun 2026 01:41:00 GMT
• early use of novocure's brain cancer therapy shows no significant survival benefit in late-stage trial PharmaLive Fri, 19 Jun 2026 00:00:48 GMT
• novocure (nvcr) experiences significant decline in stock price GuruFocus Thu, 18 Jun 2026 22:12:50 GMT
• novocure (nvcr) stock could be 31.5% undervalued after trident trial result simplywall.st Thu, 18 Jun 2026 20:35:34 GMT
• nvcr reiterated by hc wainwright & co. -- price target lowered t GuruFocus Thu, 18 Jun 2026 17:43:28 GMT
• novocure's bid to move electric fields therapy earlier in glioblastoma falls short FirstWord Pharma Thu, 18 Jun 2026 15:58:04 GMT
• novocure (nvcr) reports trident trial results for glioblastoma t GuruFocus Thu, 18 Jun 2026 15:25:40 GMT
• novocure announces topline phase 3 trident trial data for ttfields therapy in newly diagnosed glioblastoma patients – minichart Minichart Thu, 18 Jun 2026 15:19:00 GMT
• novocure (nvcr) faces 20% drop after phase 3 trial setback GuruFocus Thu, 18 Jun 2026 14:52:40 GMT
• pre-market movement | novocure's mixed news sentiment drives stock price fluctuations 富途牛牛 Thu, 18 Jun 2026 13:33:37 GMT
• why is novocure stock plummeting today? by investing.com Investing.com India Thu, 18 Jun 2026 11:55:07 GMT
• novocure's cancer treatment fails to meet late-stage trial goal TradingView Thu, 18 Jun 2026 11:15:07 GMT
• novocure ltd (nvcr) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 09:50:55 GMT
• novocure ltd (nvcr) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 09:23:42 GMT
• Novocure device fails to improve brain cancer patients’ survival in phase 3 test Fierce Biotech Thu, 18 Jun 2026 07:00:00 GMT
• Novocure Announces Topline Data from the Phase 3 TRIDENT Trial Evaluating Earlier Use of Tumor Treating Fields Therapy in Newly Di... Business Wire Thu, 18 Jun 2026 07:00:00 GMT
• Novocure’s Optune Gio fails to show benefit at earlier stage Clinical Trials Arena Thu, 18 Jun 2026 07:00:00 GMT
• Medtech Sacrifices Breakout On Its Brain Cancer Flop Investor's Business Daily Thu, 18 Jun 2026 07:00:00 GMT
• Novocure stock falls on late-stage trial setback (NVCR:NASDAQ) Seeking Alpha Thu, 18 Jun 2026 07:00:00 GMT
• Novocure stock tumbles after trial misses primary endpoint Investing.com Thu, 18 Jun 2026 07:00:00 GMT
• Novocure (NASDAQ: NVCR) Phase 3 TRIDENT glioblastoma study misses survival endpoint Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• Novocure Limited Investigation Initiated: SueWallSt Investigates the Officers and Directors of Novocure Limited (NVCR) Morningstar Thu, 18 Jun 2026 07:00:00 GMT
• Novocure Shares Slide After Phase 3 Glioblastoma Study Falls Short of Survival Goal Yahoo Finance Thu, 18 Jun 2026 07:00:00 GMT
• Novocure Brain Cancer Study Shows No Significant Survival Benefit, Stock Tanks Benzinga Thu, 18 Jun 2026 07:00:00 GMT
• early use of novocure's brain cancer therapy shows no significant survival benefit in late-stage trial TradingView Thu, 18 Jun 2026 07:00:00 GMT
• novocure fails to meet endpoint in trident trial Medical Device and Diagnostic industry Thu, 18 Jun 2026 07:00:00 GMT
• h.c. wainwright maintains novocure(nvcr.us) with buy rating, cuts target price to $46 Moomoo Thu, 18 Jun 2026 07:00:00 GMT
• novocure down nearly 18%, on track for largest percent decrease since july 2025 -- data talk Moomoo Thu, 18 Jun 2026 07:00:00 GMT
• novocure limited (nvcr) securities fraud investigation - levi & korsinsky ACCESS Newswire Thu, 18 Jun 2026 07:00:00 GMT
• novocure ltd (nvcr) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 05:51:33 GMT
• novocure ltd (nvcr) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 05:26:47 GMT
• novocure ltd (nvcr) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 05:08:53 GMT
• NovoCure (NVCR) Appoints Frank Leonard To Its Board After Shareholder Vote simplywall.st Tue, 16 Jun 2026 07:00:00 GMT
• novocure jumps after raising fy26 sales outlook, q1 revenue beat MSN Tue, 09 Jun 2026 19:28:33 GMT
• novocure ltd stock (je00b6t5s470): focus on tumor treating fields technology as investors weigh rece AD HOC NEWS Tue, 09 Jun 2026 16:04:10 GMT
• ceo sells 34k shares of biotech stock, valued at $615,000, according to latest sec filing The Motley Fool Tue, 09 Jun 2026 07:00:00 GMT
• nvcr stock gains after novocure announces positive topline results in metastatic pancreatic cancer therapy trial Stocktwits Mon, 08 Jun 2026 14:52:25 GMT
• Frank Leonard’s Board Appointment and Insider Selling Might Change The Case For Investing In NovoCure (NVCR) Yahoo Finance Mon, 08 Jun 2026 07:00:00 GMT
• novocure shareholders approve directors, auditor and incentive plan The Globe and Mail Sat, 06 Jun 2026 21:44:00 GMT
• nvcr stock gains after novocure announces positive topline results in metastatic pancreatic cancer therapy trial Stocktwits Sat, 06 Jun 2026 00:25:22 GMT
• novocure chief executive officer sold shares worth over $614k TradingView Fri, 05 Jun 2026 20:30:01 GMT
• novocure limited elects frank leonard as director, effective june 3, 2026 marketscreener.com Fri, 05 Jun 2026 20:30:00 GMT
• novocure (nasdaq: nvcr) grants rsus and stock options to director vernon w. anthony Stock Titan Fri, 05 Jun 2026 20:25:46 GMT
• novocure ltd stock (je00b6t5s470): shares jump after double-digit move puts focus on valuation AD HOC NEWS Fri, 05 Jun 2026 20:21:41 GMT
• why nvcr stock is surging nearly 30% in overnight trading Stocktwits Fri, 05 Jun 2026 18:57:45 GMT
• NovoCure (NASDAQ: NVCR) investors OK directors and tight 2024 incentive plan vote Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• novocure (nvcr) ceo sells 34,273 shares in tax-related transaction Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• novocure (nasdaq: nvcr) director granted rsus and options in new equity awards Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• novocure (nvcr) director receives new share and stock option awards Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• novocure (nvcr) grants rsus and stock options to director scannell Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• novocure (nasdaq: nvcr) awards director new rsus and stock options Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• novocure insider sold shares worth $614,635, according to a recent sec filing marketscreener.com Fri, 05 Jun 2026 07:00:00 GMT
• is it too late to buy novocure ltd (nvcr) after 11.4% rally? gf value says undervalued GuruFocus Fri, 05 Jun 2026 01:22:19 GMT
• NovoCure (NVCR) director sells 2,945 shares to cover RSU tax Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• novocure (nvcr) director executes 2,945-share sell-to-cover for rsu tax Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• novocure (nvcr) director sells 2,945 shares in tax-related trade Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• tax-driven novocure (nasdaq: nvcr) director share sale after rsu vesting Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• novocure (nvcr) director hung disposes shares in mandated tax-related sale Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• a look at novocure (nvcr) valuation as shares show mixed recent performance simplywall.st Tue, 02 Jun 2026 09:32:03 GMT
• novocure ltd stock (je00b6t5s470): nasdaq-listed cancer therapy group in focus after recent volatili AD HOC NEWS Tue, 02 Jun 2026 05:05:13 GMT
• novocure jumps after raising fy26 sales outlook, q1 revenue beat MSN Wed, 27 May 2026 03:17:07 GMT
• piper sandler maintains novocure(nvcr.us) with buy rating, maintains target price $27 富途牛牛 Wed, 27 May 2026 00:26:51 GMT
• piper sandler maintains novocure(nvcr.us) with buy rating, maintains target price $27 Moomoo Tue, 26 May 2026 11:33:00 GMT
NovoCure Limited(NASDAQ:NVCR) 
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. The company markets Optune and Optune Lua, a Tumor Treating Fields delivery system for use as a monotherapy treatment for adult patients wit...
Website: https://www.novocure.com/
Founded: 2000
Full Time Employees: 782
CEO: Asaf Danziger
Sector: Healthcare
Industry: Medical Instruments & Supplies